William L. Macias - Sep 11, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Medical Officer
Signature
/s/ William L. Macias
Stock symbol
IMVT
Transactions as of
Sep 11, 2021
Transactions value $
$0
Form type
4
Date filed
9/16/2021, 05:15 PM
Previous filing
Jun 15, 2021
Next filing
Nov 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +369K $0.00 369K Sep 11, 2021 Common Stock 369K $8.62 Direct F1
transaction IMVT Stock Option (right to buy) Disposed to Issuer $0 -369K -100% $0.00* 0 Sep 11, 2021 Common Stock 369K $10.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.